Results 1 to 10 of about 7,787,676 (175)
Trends in sociodemographic factors associated with human papillomavirus vaccine hesitancy in the United States: 2010-2022. [PDF]
Abstract Background Previous studies suggest that rates of human papillomavirus (HPV) vaccine hesitancy vary by adolescent and parent sociodemographic characteristics. This study assessed trends in the characteristics of parents who did not intend to have their child vaccinated for HPV in the United States.
Abouelella DK +5 more
europepmc +2 more sources
Human papillomavirus vaccine uptake and associated factors among schoolgirls in Sululta and Chancho towns, Central Ethiopia: a cross-sectional study [PDF]
Background Cervical cancer is the second leading cause of cancer incidence and mortality among women in Ethiopia. The introduction of the human papillomavirus (HPV) vaccine is expected to substantially reduce the burden of the disease.
Habtamu Mekonnen Kessessa +2 more
doaj +2 more sources
Objective: Safe and effective human papillomavirus vaccines are available against cervical cancer and other human papillomavirus–associated diseases. Vaccine uptake is low in India given lack of universal vaccination programme.
Seemitha Shetty +3 more
doaj +1 more source
Background Human papillomavirus vaccine uptake among school girls in Ethiopia was still low and uptake was majorly related to perception regarding the vaccine.
Abel Wubu +3 more
doaj +1 more source
Background Cervical cancer is considered a leading cause of morbidity and mortality among females worldwide. Human papillomavirus is a highly prevalent sexually transmitted infection associated with increased cancer risks.
Teferi Regasa MSc +2 more
doaj +1 more source
Background Cervical cancer is the fourth most common cancer affecting females. Human papillomavirus vaccination of adolescent girls is the primary strategy for cervical cancer prevention but in Ethiopia, it lacks emphasis.
Amare Zewdie +4 more
doaj +1 more source
Introduction: To reduce the cervical cancer burden, many governments have emphasized the Human papillomavirus (HPV) vaccine as an important prevention strategy.
Bright Twikirize +2 more
doaj +1 more source
Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study
The 4-valent human papillomavirus (HPV) vaccine (4vHPV vaccine), Gardasil®, is indicated for the prevention of several HPV-related diseases. The objective was to assess the safety of 4vHPV vaccine administered to males as part of routine care.
Kandace L. Amend +6 more
doaj +1 more source
Background: Vaccines are among the most effective and cost-efficient public health interventions for promoting child health. However, uptake is considerably affected by vaccine hesitancy.
Gbadebo Collins Adeyanju +3 more
doaj +1 more source

